Comment from FFVH

AnonymousOpposeBusiness
Summary: A feline-only veterinary hospital is opposing the removal of Ponazuril from the office stock list. They argue that the current commercial alternative is unsuitable for cats and that its removal hinders timely, cost-effective treatment for their patients.
I received an email regarding Ponazuril being removed from office stock ordering. We are a feline-only veterinary hospital and often dispense small amounts of Ponazuril for cats and kittens. The available commercial product is a horse paste that cannot be used in cats. Removing Ponazuril from the available for office stock list creates an issue for timely, cost-effective treatment of coccidia in our patients.

View on Regulations.gov